Foundation Medicine (FMI) Tops Q1 EPS by 8c

Foundation Medicine (NASDAQ: FMI) reported Q1 EPS of ($1.02), $0.08 better than the analyst estimate of ($1.10). Revenue for the quarter came in at $52.8 million versus the consensus estimate of $44.92 million.

GUIDANCE:

Foundation Medicine sees FY2018 revenue of $200-220 million, versus the consensus of $212.3 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• L3Harris CEO steps down amid conduct review, shares drop
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c